Literature DB >> 19745607

The presence of CD8+ invariant NKT cells in mice.

Hyunji Lee1, Changwan Hong, Junghoon Shin, Soohwan Oh, Sundo Jung, Yoon-Kyung Park, Seokmann Hong, Gap Ryol Lee, Se-Ho Park.   

Abstract

Invariant natural killer T (iNKT) cells develop in the thymus upon recognition of CD1d expressed on developing thymocytes. Although CD4 and CD8 coreceptors are not directly involved in the interaction between CD1d and the T cell receptors (TCRs) of iNKT cells, a conspicuous lack of CD8(+) iNKT cells in mice raised the question of whether CD8(+) iNKT cells are excluded due to negative selection during their thymic development, or if there is no lineage commitment for the development of murine CD8(+) iNKT cells. To address this question, we analyzed iNKT cell-specific TCR V alpha 14(+) transgenic mice, where the V alpha 14 transgene forces the generation of iNKT cells. This allows detailed study of the iNKT cell repertoire. We were able to identify CD8(+) iNKT cells which respond to the NKT cell-specific glycolipid ligand alpha-galactosylceramide. Unlike conventional iNKT cells, CD8(+) iNKT cells produce predominantly IFN-gamma but not IL-4 upon antigen stimulation. We also confirmed the presence of CD8(+) iNKT cells in wild type mice. Our results suggest that CD8(+) NKT cells do exist in mice, although their population size is quite small. Their Th1-skewed phenotype might explain why the population size of this subtype needs to be controlled tightly.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19745607      PMCID: PMC2802682          DOI: 10.3858/emm.2009.41.12.092

Source DB:  PubMed          Journal:  Exp Mol Med        ISSN: 1226-3613            Impact factor:   8.718


  22 in total

1.  Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells.

Authors:  G Eberl; R Lees; S T Smiley; M Taniguchi; M J Grusby; H R MacDonald
Journal:  J Immunol       Date:  1999-06-01       Impact factor: 5.422

Review 2.  NKT cells: what's in a name?

Authors:  Dale I Godfrey; H Robson MacDonald; Mitchell Kronenberg; Mark J Smyth; Luc Van Kaer
Journal:  Nat Rev Immunol       Date:  2004-03       Impact factor: 53.106

Review 3.  Toward an understanding of NKT cell biology: progress and paradoxes.

Authors:  Mitchell Kronenberg
Journal:  Annu Rev Immunol       Date:  2005       Impact factor: 28.527

Review 4.  Mouse CD1-specific NK1 T cells: development, specificity, and function.

Authors:  A Bendelac; M N Rivera; S H Park; J H Roark
Journal:  Annu Rev Immunol       Date:  1997       Impact factor: 28.527

5.  Evidence for a differential avidity model of T cell selection in the thymus.

Authors:  P G Ashton-Rickardt; A Bandeira; J R Delaney; L Van Kaer; H P Pircher; R M Zinkernagel; S Tonegawa
Journal:  Cell       Date:  1994-02-25       Impact factor: 41.582

Review 6.  The CD69 receptor: a multipurpose cell-surface trigger for hematopoietic cells.

Authors:  R Testi; D D'Ambrosio; R De Maria; A Santoni
Journal:  Immunol Today       Date:  1994-10

7.  Role of monocytes in the up-regulation of the early activation marker CD69 on B and T murine lymphocytes induced by microbial mitogens.

Authors:  M Vilanova; D Tavares; P Ferreira; L Oliveira; A Nóbrega; R Appelberg; M Arala-Chaves
Journal:  Scand J Immunol       Date:  1996-02       Impact factor: 3.487

8.  The timing of TCR alpha expression critically influences T cell development and selection.

Authors:  Troy A Baldwin; Michelle M Sandau; Stephen C Jameson; Kristin A Hogquist
Journal:  J Exp Med       Date:  2005-07-04       Impact factor: 14.307

9.  Increased interleukin 4 and immunoglobulin E production in transgenic mice overexpressing NK1 T cells.

Authors:  A Bendelac; R D Hunziker; O Lantz
Journal:  J Exp Med       Date:  1996-10-01       Impact factor: 14.307

10.  An invariant T cell receptor alpha chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4-8- T cells in mice and humans.

Authors:  O Lantz; A Bendelac
Journal:  J Exp Med       Date:  1994-09-01       Impact factor: 14.307

View more
  5 in total

1.  Clusterin synergizes with IL-2 for the expansion and IFN-γ production of natural killer cells.

Authors:  Chung Hee Sonn; Young-Bin Yu; Young-Joo Hong; Young-Jun Shim; Jeffrey A Bluestone; Bon-Hong Min; Kyung-Mi Lee
Journal:  J Leukoc Biol       Date:  2010-08-20       Impact factor: 4.962

2.  Endotoxin-induced lung injury in α-galactosylceramide-sensitized mice is caused by failure of interleukin-4 production in lung natural killer T cells.

Authors:  J Dagvadorj; G Tumurkhuu; Y Naiki; A S M Noman; I Iftakhar-E-Khuda; B Badamtseren; T Komatsu; N Koide; T Yoshida; T Yokochi
Journal:  Clin Exp Immunol       Date:  2010-08-19       Impact factor: 4.330

Review 3.  Natural Killer T Cells in Cancer Immunotherapy.

Authors:  Shiny Nair; Madhav V Dhodapkar
Journal:  Front Immunol       Date:  2017-09-22       Impact factor: 7.561

4.  Augmentation of natural cytotoxicity by chronic low-dose ionizing radiation in murine natural killer cells primed by IL-2.

Authors:  Chung Hee Sonn; Jong Rip Choi; Tae-Jin Kim; Young-Bin Yu; Kwanghee Kim; Suk Chul Shin; Gil-Hong Park; Toshiro Shirakawa; Hee Sun Kim; Kyung-Mi Lee
Journal:  J Radiat Res       Date:  2012-08-21       Impact factor: 2.724

Review 5.  Antitumor Responses of Invariant Natural Killer T Cells.

Authors:  Jennie B Altman; Adriana D Benavides; Rupali Das; Hamid Bassiri
Journal:  J Immunol Res       Date:  2015-10-12       Impact factor: 4.818

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.